首页> 外国专利> PAIP, A NOVEL HUMAN PROTEIN WHICH BRIDGES THE 3' AND 5' END OF MRNA, AND USE THEREOF AS A TARGET FOR TRANSLATIONAL MODULATION TO TREAT HUMAN DISEASE

PAIP, A NOVEL HUMAN PROTEIN WHICH BRIDGES THE 3' AND 5' END OF MRNA, AND USE THEREOF AS A TARGET FOR TRANSLATIONAL MODULATION TO TREAT HUMAN DISEASE

机译:PAIP,一种新型的人类蛋白质,可桥接MRNA的3'和5'末端,并以此为靶标进行翻译调节以治疗人类疾病

摘要

The present invention relates to the process of proteinsynthesis in eukaryotic cells. More particularly, the present inventionrelates to translation and more specifically to the initiation of translationin such cells. More specifically, the present invention relates to proteinsinvolved in the initiation of translation in animal cells, to the modulationoftranslation thereby and to the coupling of the 3' and 5' ends mRNA by theproteins of the present invention. The present invention also relates toisolated nucleic acid molecules encoding a human protein, a bindingProtein-Interacting Protein (PAIP), as well as vectors, host cells harboringsame. In addition, the present invention relates to screening assays foridentifying modulators of PAIP activity.
机译:本发明涉及蛋白质的过程真核细胞中的合成。更具体地说,本发明与翻译有关,更具体地说,与翻译的开始有关在这样的细胞中。更具体地,本发明涉及蛋白质参与动物细胞翻译的启动,调节的从而翻译并与3'和5'末端mRNA的偶联通过本发明的蛋白质。本发明还涉及分离的编码人类蛋白质的核酸分子蛋白质相互作用蛋白(PAIP)以及载体,宿主细胞相同。另外,本发明涉及针对确定PAIP活性的调节剂。

著录项

  • 公开/公告号CA2227508A1

    专利类型

  • 公开/公告日1999-10-01

    原文格式PDF

  • 申请/专利权人 UNIVERSITE MCGILL;

    申请/专利号CA19982227508

  • 发明设计人 SONENBERG NAHUM;

    申请日1998-04-01

  • 分类号C12N15/12;A61K31/70;A61K38/17;A61K48/00;C07K14/47;

  • 国家 CA

  • 入库时间 2022-08-22 02:24:04

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号